Trulicity ® (dulaglutide) injection

0.75 mg/0.5 mL, 1.5 mg/0.5 mL

For questions regarding this product, please see: Full Prescribing Information

The below information is provided in response to your request and may contain information about doses, uses, formulations and populations different from product labeling. See Prescribing Information above.

TRULICITY® (dulaglutide): QTC Interval

At supratherapeutic doses (4 and 7 mg), Trulicity (dulaglutide) does not prolong QTc.

At supratherapeutic doses (4 and 7 mg), Trulicity® (dulaglutide) does not prolong QTc (Trulicity Package Insert, 2017).

Enclosed Prescribing Information

TRULICITY® (dulaglutide) injection, for subcutaneous use, Lilly

The published reference below is available upon request by contacting 1-800-LillyRx.

Reference

Trulicity [package insert]. Indianapolis, IN: Eli Lilly and Company; 2017.

Date of Last Review: May 09, 2017

Contact Lilly

Call Us

If you need information about a Lilly product or want to report an Adverse Event or Product Complaint, you may call us.

Available Mon - Fri, 9am - 8pm ET

Or you can

Ask us a question Chat with us

Submit a question

Visit Us @LillyMedical